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General methods 
All reactions except for peptide synthesis were carried out under a positive pressure of 
argon. For column chromatography, silica gel (KANTO KAGAKU N-60) was 
employed. Mass spectra were recorded on a Waters MICROMASS
®
 LCT PREMIER
TM
 
(ESI-TOF). NMR spectra were recorded using a Bruker AV400N at 400 MHz frequency 
for 
1
H, and JEOL JNM-AL300 at 75 MHz frequency for 
13
C. For HPLC separations, a 
Cosmosil 5C18-AR-II analytical column (Nacalai Tesque, 4.6 × 250 mm, flow rate 1.0 
mL min
-1
), a Cosmosil Protein-R analytical column (Nacalai Tesque, 4.6 × 250 mm, 
flow rate 1.0 mL min
-1
), a Cosmosil Protein-R semi-preparative column (Nacalai Tesque, 
10 × 250 mm, flow rate 3.0 mL min
-1
) or a Cosmosil 5C18-AR-II preparative column 
(Nacalai Tesque, 20 × 250 mm, flow rate 10 mL min
-1
) was employed, and eluting 
products were detected by UV at 220 nm. A solvent system consisting of 0.1% TFA 
aqueous solution (v/v, solvent A) and 0.1% TFA in MeCN (v/v, solvent B) was used for 
HPLC elution. Optical rotations were measured using a JASCO P-2200 polarimeter 
(concentration in g dL
-1
). Measurement of absorbance at 280 nm was performed using a 
Thermo Scientific™ NanoDrop™ 8000. CD spectrum was recorded with a JASCO 
J1500 spectropolarimeter. 
 
 
Synthesis of N-glycosylated asparagine derivative 1 
 
Protected aspartate 8 was synthesized similarly to its enantiomer.
[S1]
 To ice-cold allyl 
alcohol (50.0 mL) was added acetyl chloride (7.10 mL, 100 mmol). The reaction 
mixture was stirred at the same temperature for 15 min followed by at room temperature 
for 1 hour, and then L-aspartic acid (3.33 g, 25.0 mmol) was added. The resulting 
mixture was stirred at room temperature for 23 hours and was poured into ice-cold Et2O 
(250 mL) to give precipitate. After being stirred at 0 °C for 1 hour, the precipitate was 
collected by filtration and was washed with Et2O to give the aspartic acid β-allyl ester as 
a white powder (4.05 g, 77%). To the solution of the allyl ester (3.50 g, 16.7 mmol) in 
water (25.0 mL) were added Boc2O (4.37 g, 20.0 mmol) in dioxane (25.0 mL) and Et3N 
(6.50 mL, 46.8 mmol), and then the solution was stirred at room temperature for 3 hours. 
After the reaction mixture was washed with Et2O, the aqueous phase was acidified by 
10% (w/v) citric acid aq. to pH 4–5 and then was extracted into EtOAc. The organic 
S3 
 
phase was successively washed with 10% (w/v) citric acid aq. and brine, and then dried 
over Na2SO4. Filtration of the mixture followed by concentration under reduced 
pressure gave the N-Boc-aspartate as a colorless oil (4.53 g, 99%). To the solution of the 
resulting compound (4.00 g, 14.6 mmol) in DMF (50.0 mL) was added K2CO3 (6.07 g, 
43.9 mmol) and the reaction mixture was stirred at room temperature for 2 hours. Then 
iodomethane (2.73 mL, 43.9 mmol) was added and the resultant mixture was stirred for 
additional 12 hours. After DMF was evaporated, the residue was dissolved in EtOAc. 
The organic phase was washed with 1 M HCl aq., saturated NaHCO3 aq., 5% (w/v) 
Na2S2O3 aq. and brine, and then dried over Na2SO4. After filtration and subsequent 
removal of the solvent under reduced pressure, chromatographic purification on silica 
gel (n-hexane/EtOAc = 5:1, (v/v)) gave the fully protected aspartate 8 in 86% isolated 
yield (3.62 g) as a colorless oil. The NMR spectrum was identical to that of the 
enantiomer: [α]18D -14.3 (c 0.96, MeOH);
 1H NMR (CDCl3, 400 MHz) δ = 1.45 (9H, s), 
2.85 (1H, dd, 17.0 and 4.9 Hz), 3.03 (1H, dd, 17.0 and 4.6 Hz), 3.76 (3H, s), 4.60 (2H, 
ddd, 5.8, 1.3 and 1.4 Hz), 4.52–4.67 (1H, m), 5.25 (1H, ddt, 10.4, 1.4 and 1.3 Hz), 5.32 
(1H, ddt, 17.2, 1.4 and 1.4 Hz), 5.49 (1H, br d, 7.7 Hz), 5.90 (1H, ddt, 17.2, 10.4 and 
5.8 Hz); 
13
C NMR (CDCl3, 75 MHz) δ = 28.2, 36.7, 49.9, 52.5, 65.5, 79.8, 118.4, 131.7, 
155.2, 170.5, 171.4.
 
 
 
To a solution of 8 (3.26 g, 11.4 mmol) in THF (120 mL) at -78 °C was added LiHMDS 
(1 M in THF, 25.0 mL, 25.0 mmol) and the reaction mixture was stirred at the same 
temperature for 2 hours. Then a solution of 
S-(2,4,6-trimethoxybenzyl)toluenethiosulfonate 9
[S2]
 (5.88 g, 16.0 mmol) in THF (60.0 
mL) was added and the resultant was stirred for additional 3 hours at -78 °C. After 
quenching with saturated NH4Cl aq., THF was removed under reduced pressure, and the 
residue was extracted with EtOAc. The organic phase was successively washed with 
saturated NH4Cl aq. and brine, and then dried over Na2SO4. After filtration followed by 
removal of the solvent in vacuo, Et2O was added to give precipitate. The precipitate was 
filtrated off and the filtrate was concentrated under reduced pressure. The residue was 
purified by silica gel column chromatography (n-hexane/EtOAc = 4:1 to 3:1, (v/v)) to 
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give a diastereomeric mixture of 10 (7:2) as a pale yellow oil (4.64 g, 81%). The major 
diastereomer was isolated for characterization: [α]19D 57.7 (c 0.96, MeOH);
  
1
H NMR 
(CDCl3, 400 MHz) δ = 1.44 (9H, s), 3.70 (3H, s), 3.81 (9H, s), 3.90 (1H, br d, 12.8 Hz), 
3.99 (1H, br d, 12.8 Hz), 4.12 (1H, br d, 4.3 Hz), 4.59 (2H, br d, 5.6 Hz), 4.82 (1H, br 
dd, 9.6 and 4.3 Hz), 5.23 (1H, dq, 10.6 and 1.1 Hz), 5.33 (1H, bq, 17.3 and 1.4 Hz), 
5.66 (1H, br d, 9.6 Hz), 5.87 (1H, ddt, 17.3, 10.6 and 5.6 Hz), 6.11 (2H, s); 
13
C NMR 
(CDCl3, 75 MHz) δ = 25.0, 28.4, 48.5, 52.6, 55.0, 55.4, 55.8, 55.8, 66.1, 80.0, 90.6, 90.6, 
106.9, 118.4, 118.5, 131.7, 155.9, 159.0, 159.0, 160.7, 171.0, 171.5; HRMS (ESI-TOF) 
m/z calcd for C23H33NNaO9S ([M + Na]
+
): 522.1774, found 522.1780. 
 
 
Allyl ester 10 (4.00 g, 8.01 mmol, diastereomeric mixture) in THF (30.0 mL) was 
treated with N-methylaniline (8.71 mL, 80.1 mmol) and Pd(PPh3)4 (185 mg, 0.160 
mmol). After being stirred at room temperature for 2 hours, the reaction mixture was 
concentrated in vacuo and the product was purified by silica gel column 
chromatography (n-hexane/EtOAc/AcOH = 2:1:0.05 to 3:2:0.05, (v/v)) to give a 
diastereomeric mixture of 11 (7:2) as a pale yellow amorphousness (3.31 g, 90%). The 
major diastereomer was isolated for characterization: [α]19D 41.6 (c 0.98, MeOH); 
1
H 
NMR (CDCl3, 400 MHz) δ = 1.45 (9H, s), 3.72 (3H, s), 3.81 (3H, s), 3.82 (6H, s), 3.95 
(2H, s), 4.12 (1H, br d, 3.7 Hz), 4.89 (1H, br dd, 9.9 and 3.7 Hz), 5.52 (1H, brd, 9.9 Hz), 
6.13 (2H, s); 
13
C NMR (CDCl3, 75 MHz) δ = 25.3, 28.4, 52.9, 55.0, 55.5, 55.9, 55.9, 
80.3, 90.7, 106.6, 155.9, 159.0, 160.9, 160.9, 170.8, 170.8; HRMS (ESI-TOF) m/z calcd 
for C20H29NNaO9S ([M + Na]
+
): 482.1461, found 482.1460. 
 
 
Compound 11 (2.01 g, 4.37 mmol, diastereomeric mixture) in CH2Cl2 (15.0 mL) was 
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treated with pentafluorophenol (687 μL, 6.56 mmol) and EDC·HCl (1.01 g, 5.24 mmol). 
After being stirred at room temperature for 1 hour, the mixture was concentrated in 
vacuo. EtOAc was added to the residue and the obtained solution was washed with 
water, saturated NaHCO3 aq., saturated NH4Cl aq. and brine. After drying over Na2SO4 
followed by filtration, the organic layer was concentrated under reduced pressure. The 
obtained residue was subjected to chromatographic purification on silica gel 
(n-hexane/EtOAc = 3:1, (v/v)) to give a diastereomeric mixture of 12 (1:1) in 81% 
isolated yield (2.21 g) as a colorless amorphousness. Less polar diastereomer was 
isolated for characterization: [α]18D 108.4 (c 0.93, CHCl3);
 1H NMR (CDCl3, 400 MHz) 
δ = 1.44 (9H, s), 3.74 (3H, s), 3.80 (3H, s), 3.83 (6H, s), 4.02 (2H, s), 4.39 (1H, br d, 4.8 
Hz), 4.98 (1H, br dd, 10.1 and 4.8 Hz), 5.49 (1H, br d, 10.1 Hz), 6.12 (2H, s); 
13
C NMR 
(CDCl3, 75 MHz) δ = 25.5, 28.4, 48.3, 52.9, 55.0, 55.4, 55.8, 55.8, 80.4, 90.6, 90.6, 
106.5, 124.9, 138.0 (d, 246.6 Hz), 139.7 (d, 251.6 Hz), 141.3 (d, 246.6 Hz), 155.6, 
159.1, 159.1, 160.9, 168.2, 170.2; HRMS (ESI-TOF) m/z calcd for C26F5H28NNaO9S 
([M + Na]
+
): 648.1303, found 648.1292. 
 
 
Tributylphosphine (1.40 mL, 5.60 mmol) was added to a stirred solution of 
pentafluorophenyl ester 12 (1.75 g, 2.80 mmol, diastereomeric mixture), 
2-acetamido-3,4,6-tri-O-benzyl-2-deoxy-β-D-glucopyranosyl azide 13 (2.17 g, 4.20 
mmol, commercially available), and 3-hydroxy-1,2,3-benzotriazin-4(3H)-one (HOOBt, 
456 mg, 2.80 mmol) in THF containing 2% (v/v) H2O (28.0 mL) at 0 °C. The mixture 
was stirred at room temperature for 16 hours, and then the solvent was evaporated in 
vacuo. MeOH/CH2Cl2 (9:1, (v/v)) was added to the residue and the solution was washed 
with water and brine. The organic layer was then dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The product was purified by silica gel column 
chromatography (CHCl3) followed by reprecipitation from n-hexane/EtOAc to afford a 
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5:1 of diastereomeric mixture of 12 as a white amorphousness (1.26 g, 48%). Major 
diastereomer was isolated for characterization: [α]18D -6.7 (c 0.82, CHCl3);
 1H NMR 
(CDCl3, 400 MHz) δ = 1.39 (9H, s), 1.89 (3H, s), 3.53–3.58 (1H, m), 3.59 (3H, s), 3.62–
3.71 (2H, m), 3.71–3.77 (4H, m), 3.78 (9H, s), 3.87 (1H, d, 12.4 Hz), 4.00 (1H, t, 9.8 
Hz), 4.51 (1H, d, 11.9 Hz), 4.57 (1H, d, 11.9 Hz), 4.61 (1H, d, 11.2 Hz), 4.67 (1H, brs), 
4.70 (1H, d, 11.3 Hz), 4.77 (1H, d,11.2 Hz), 4.80 (1H, d, 11.3 Hz), 4.97, (1H, d, 9.8 Hz), 
6.19 (1H, s), 7.16–7.42 (15H, m); 13C NMR (CDCl3, 75 MHz) δ = 23.1, 26.0, 28.7, 51.7, 
52.9, 55.2, 55.8, 56.3, 56.3, 56.8, 69.8, 74.4, 75.9, 76.2, 77.9, 79.4, 80.5, 84.7, 91.8, 
91.8, 106.7, 128.7, 128.7, 128.7, 128.8, 129.0, 129.2, 129.4, 129.4, 139.4, 139.6, 139.9, 
160.2, 160.2, 162.5, 172.2, 172.8, 174.0; HRMS (ESI-TOF) m/z calcd for 
C49H61N3NaO13S ([M + Na]
+
): 954.3823, found 954.3787. 
 
 
Methyl ester 14 (0.30 g, 0.32 mmol) in 1,2-dichloroethane (3.0 mL) was treated with 
trimethyltin hydroxide (0.18 g, 0.97 mmol). After 10 hours reaction at 50 °C, the solvent 
was removed under reduced pressure. The residue was dissolved in EtOAc and the 
solution was washed with 5% (w/v) KHSO4 aq. and brine. After drying over Na2SO4 
followed by filtration, the organic layer was concentrated in vacuo. The crude product 
was purified by silica gel column chromatography (EtOAc/MeOH/AcOH = 95:5:0.5, 
(v/v)) afforded 1 (dr = 5:1) in 69% isolated yield (0.20 g) as a colorless amorphousness. 
The obtained diastereomeric mixture was used to a subsequent reaction without 
separation: 
1
H NMR (CDCl3, 400 MHz) δ = 1.48–1.49 (9H), 1.89 (3H, s), 3.48–4.01 
(17H), 4.51 (1H, d, 11.8Hz), 4.59, (1H, d, 11.8 Hz), 4.61 (1H, d, 11.0 Hz), 4.65–4.83 
(1H, m), 4.69 (1H, d, 11.3 Hz), 4.77 (1H, d, 10.5 Hz), 4.80 (1H, d, 11.0 Hz), 4.91–5.01 
(1H, m), 6.18–6.22 (2 H, s), 7.10–7.45 (15H, m); 13C NMR (CDCl3, 75 MHz) δ = 23.1, 
26.3, 28.7, 52.1, 55.2, 55.8, 56.3, 56.3, 56.8, 69.8, 74.4, 75.9, 76.2, 77.9, 79.4, 80.6, 
84.6, 91.9, 91.9, 106.8, 128.7, 128.7, 128.7, 129.0, 129.1, 129.4, 129.4, 129.4, 139.4, 
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139.6, 139.9, 160.2, 160.2, 162.4, 173.0, 173.4, 174.0; HRMS (ESI-TOF) m/z calcd for 
C48H59N3NaO13S ([M + Na]
+
): 940.3666, found 940.3653. 
 
 
Preparation of SEAlide peptide 2 
On Rink amide ChemMatrix resin (0.54 mmol amine/g, 0.46 g, 0.25 mmol) was 
coupled Fmoc-Leu-OH (4.0 equiv) with the aid of N,N’-diisopropylcarbodiimide 
(DIPCDI, 4.0 equiv) and HOBt·H2O (4.0 equiv) in DMF at room temperature for 2 
hours. Then Fmoc removal was performed with 20% (v/v) piperidine in DMF to give a 
Leu-incorporated resin. The resulting resin was treated with an 
Fmoc-Ser(
t
Bu)-incorporating N-sulfanylethylaniline(SAcm) linker
[S3]
 (2.0 equiv), 
DIPCDI (2.0 equiv), and HOBt·H2O (2.0 equiv) to yield the SEAlide-linked resin. On 
this resin, peptide was elongated using standard Fmoc-based protocols (4.0 equiv each 
of amino acid using DIPCDI (4.0 equiv) and HOBt·H2O (4.0 equiv) in DMF (2 hours) 
and Fmoc removal with 20% piperidine in DMF (10 min)). On the N-terminus of the 
resin, 1 (2.0 equiv) was coupled with the aid of PyBop (2.1 equiv) and DIEA (4.0 equiv) 
in DMF at room temperature for 3 hours. A portion of the resulting resin (500 mg) was 
treated with 1 M TMSBr-thioanisole in TFA (50 μL/1 mg resin)/m-cresol/EDT (100/5/5, 
(v/v)) at 4 °C for 2 hours. The resin in the reaction mixture was filtrated off. To the 
resulting filtrate was added cooled Et2O to give precipitate. The formed precipitate was 
collected by centrifugation and thoroughly washed with Et2O to afford crude SEAlide 
peptide 2. The peptide was purified by preparative HPLC (Cosmosil 5C18-AR-II 
preparative column with a linear gradient of solvent B in solvent A over 30 min: 34% to 
40%) to afford purified SEAlide peptide 2 (16.3 mg from 500 mg of the protected 
resin). 
Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 30% to 50% over 30 min, retention time = 15.8 min, 
MS (ESI-TOF) m/z calcd ([M + 4H]
4+
) 1307.7, found 1307.4. 
 
 
One-pot ligation/desulfurization between SEAlide peptide 2 and peptide 
thioester 3 
Peptide thioester 3 (11 mg, 2.7 μmol) and N-glycosylated asparagine 
derivative-incorporating SEAlide peptide 2 (15 mg, 2.7 μmol) were dissolved in 2.7 mL 
of 6 M Gn·HCl-0.1 M Na phosphate, 3% (v/v) TFET, pH 7.3, and the solution was 
incubated at 37 °C. The reaction was completed within 8 hours. After treatment of the 
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reaction mixture with nitrogen stream, to the reaction mixture were added 2.7 mL of 
aqueous solution of Gn·HCl (6 M) and TCEP·HCl (0.4 M), pH 7.0, reduced form 
glutathione (in solid form, 40 mM) and VA-044 (in solid form, 20 mM). After 
incubation at 37 °C for additional 18 hours, the crude product was purified by 
semi-preparative HPLC (Cosmosil Protein-R semi-preparative column with a linear 
gradient of solvent B in solvent A over 30 min: 38% to 41%) to give purified 
Acm-protected SEAlide peptide 5 (13 mg, 1.4 μmol, 53%). 
Analytical HPLC conditions: Cosmosil Protein-R analytical column with a linear 
gradient of solvent B in solvent A, 30% to 50% over 30 min, retention time = 20.0 min, 
MS (ESI-TOF) m/z calcd ([M + 8H]
8+
) 1076.6, found 1076.6. 
 
 
Acm removal for preparation of native N-half fragment 6 
The Acm-protected peptide 5 (13 mg, 1.4 μmol) was treated with AgOTf (36 mg, 0.14 
mmol) and anisole (15 μL, 0.14 mmol) in TFA (340 μL, 4.0 mM peptide) at 4 °C. After 
13 hours, to the reaction mixture was added cooled Et2O to give precipitate. The formed 
precipitate was collected by centrifugation and thoroughly washed with Et2O. The 
resulting crude peptide was dissolved in 4 mL solution of 6 M Gn·HCl-0.2 M HEPPS 
buffer (pH 6.1) containing 5% (w/v) dithiothreitol. The suspension was incubated at 
37 °C for 30 min and then 4 mL of 6 M Gn·HCl aq. was added. After filtration, the 
filtrate was purified by semi-preparative HPLC (Cosmosil Protein-R semi-preparative 
column with a linear gradient of solvent B in solvent A over 30 min: 40% to 43%) to 
afford the purified 6 (7.0 mg, 0.77 μmol, 54%). 
Analytical HPLC conditions: Cosmosil Protein-R analytical column with a linear 
gradient of solvent B in solvent A, 30% to 50% over 30 min, retention time = 23.6 min, 
MS (ESI-TOF) m/z calcd ([M + 8H]
8+
) 1049.9, found 1049.7. 
 
Fig. S1 HPLC analysis of Acm-removed crude materials after 13 hours reaction 
followed by dithiothreitol treatment. 
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Convergent assembly of native N-half fragment 6 and C-half fragment 7 
The native N-half fragment 6 (3.7 mg, 0.34 μmol) and the C-half fragment 7[S3] (3.1 mg, 
0.34 μmol) were dissolved in 6 M Gn·HCl-0.5 M Na phosphate buffer containing 50 
mM TCEP·HCl and 50 mM MPAA (pH 6.1, 0.68 mL) and the mixture was incubated at 
37 °C. After 30 hours, the reaction mixture was diluted with 3 mL of 6 M Gn·HCl aq. 
with 0.5% (w/v) TCEP·HCl, and then the crude peptide was purified by 
semi-preparative HPLC (Cosmosil Protein-R semi-preparative column with a linear 
gradient of solvent B in solvent A over 30 min: 43% to 46% over 30 min) to give 
purified reduced form of native GM2AP 15 (2.6 mg, 0.14 μmol, 40%). 
Analytical HPLC conditions: Cosmosil Protein-R analytical column with a linear 
gradient of solvent B in solvent A, 35% to 55% over 30 min, retention time = 20.9 min, 
MS (ESI-TOF) calcd (average isotopes) 17792.4, found 17793.4. 
 
 
Folding for preparation of monoglycosylated GMAP 
The reduced form GM2AP 15 (1.0 mg) was dissolved in DMSO (0.50 mL). The 
resulting solution was added to 50 mM 
3-[4-(2-hydroxyethyl)piperazin-1-yl]propane-1-sulfonic acid (HEPPS) buffer containing 
1.0 mM reduced form glutathione, 0.10 mM oxidized form glutathione and 1.0 mM 
EDTA (pH 8.0, 9.5 mL, final concentration of protein 0.10 mg mL
-1
). After being stored 
at 37 °C for 24 hours, the folded protein was purified by semi-preparative HPLC 
(Cosmosil Protein-R semi-preparative column with a linear gradient of solvent B in 
solvent A over 30 min: 35% to 55% over 30 min) to give purified monoglycosylated 
native GM2AP (0.52 mg, 52%, determined by measurement of absorbance at 280 nm 
(ε280 = 22960, calculated as previously reported
[S4]
)).  
Analytical HPLC conditions: Cosmosil Protein-R analytical column with a linear 
gradient of solvent B in solvent A, 35% to 55% over 30 min, retention time = 17.0 min, 
MS (ESI-TOF) calcd (average isotopes) 17784.4, found 17783.7. 
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Fig. S2 (A) HPLC analysis of purified monoglycosylated GM2AP. (B) Mass spectrum 
of synthesized GM2AP. 
 
 
CD measurement of monoglycosylated GM2AP 
CD spectrum of the GM2AP (10 mM citrate buffer, pH 4.5, 0.067 mg mL
-1
 (determined 
by Bio-Rad DC protein assay)) in the range of 200 to 260 nm was recorded at 25 °C in a 
0.2 mm-path quartz cuvette. Molar mean-residue ellipticity [θ] (deg cm2 dmol-1) was 
calculated as [θ] = θ·100/(l·c·A). The θ is the observed ellipticity (mdeg) and the l is the 
length of the optical path (cm). The c is the protein concentration (mmol L
-1
) and the A 
is the number of amino acids contained in the protein. 
 
Fig. S3 CD spectrum of synthesized monoglycosylated GM2AP. 
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In vitro GM2-degradation assay of synthesized GM2AP 
In vitro GM2-degradation assay was performed as described previously.
[S5]
 Briefly, the 
GM2 ganglioside was incubated with recombinant human HexA (2000 nmol h
-1
 
4-methylumbellifery-6-sulfo-β-D-glucosaminide potassium salt (4-MUGS)-degrading 
activity) in the presence or absence of 5 μg of synthesized GM2AP in 10 mM sodium 
citrate buffer (pH 4.5) containing 0.1% bovine serum albumin (BSA) at 37 °C for 22 
hours. After the incubation, the reaction was stopped by heating the tube with boiling 
water for 3 min, and then glycosphingolipids (GSLs) were isolated using a C18 Sep-Pak 
Cartridge. Aliquots of samples were spotted on a silica gel plate and developed with 
CHCl3/MeOH/0.2% (w/v) CaCl2 aq. (60:40:9, (v/v)). To reveal GSLs, the thin-layer 
chromatography plate was sprayed with orcinol reagent and heated at 120 °C for 5 min. 
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